Insider · CIK 0001852291

Wang Lai

Reports to the SEC for 1 company · BASEL

sec.gov

Transactions

Companies

Filings

CIK

0001852291

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,068 sh	$276.74	−$296K	0
2026-06-16	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,169 sh	$265.39	−$310K	0
2026-06-11	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+119K sh	—	—	1,710,085
2026-06-11	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−756 sh	$261.00	−$197K	0
2026-06-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	President, Global Head of R&D	AAward	+230K sh	—	—	229,775
2026-06-08	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,327 sh	$269.34	−$357K	40
2026-06-08	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−40 sh	$270.73	−$10.8K	0
2026-03-06	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+113K sh	—	—	1,564,030
2026-03-06	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+55K sh	—	—	1,619,059
2025-12-31	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+428K sh	—	—	1,451,424
2025-09-09	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−5,000 sh	$350.06	−$1.75M	0
2025-07-30	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−259 sh	$305.00	−$79K	0
2025-07-29	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−2,949 sh	$302.00	−$891K	1,351
2025-07-29	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−292 sh	$302.92	−$88.5K	1,059
2025-07-29	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−800 sh	$304.16	−$243K	259
2025-07-18	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−700 sh	$300.00	−$210K	0
2025-06-23	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,028 sh	$260.00	−$267K	0
2025-06-17	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−470 sh	$251.37	−$118K	0
2025-06-16	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,177 sh	$266.40	−$314K	470
2025-06-10	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+86.4K sh	—	—	1,058,304
2025-06-10	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	President, Global Head of R&D	AAward	+163K sh	—	—	162,565
2025-06-06	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−600 sh	$250.71	−$150K	802
2025-06-06	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−202 sh	$251.89	−$50.9K	600
2025-06-06	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−300 sh	$253.19	−$76K	300
2025-06-06	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−300 sh	$255.30	−$76.6K	0
2025-03-05	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+69.3K sh	—	—	990,171
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,327 sh	$254.82	−$338K	3,673
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−575 sh	$255.86	−$147K	3,098
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−479 sh	$256.70	−$123K	2,619
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−437 sh	$258.18	−$113K	2,182
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,782 sh	$258.73	−$461K	400
2025-02-21	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−400 sh	$260.17	−$104K	0
2024-09-27	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−5,000 sh	$220.35	−$1.1M	0
2024-06-24	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,062 sh	$159.80	−$170K	2
2024-06-24	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−2 sh	$161.10	−$322.2	0
2024-06-18	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−841 sh	$153.75	−$129K	0
2024-06-17	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−237 sh	$158.50	−$37.6K	2,104
2024-06-17	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−478 sh	$159.00	−$76K	1,626
2024-06-17	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−485 sh	$159.42	−$77.3K	1,141
2024-06-17	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−300 sh	$159.90	−$48K	841
2024-06-05	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+169K sh	—	—	1,768,962
2024-06-05	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	President, Global Head of R&D	AAward	+318K sh	—	—	318,253
2023-06-26	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,103 sh	$181.91	−$201K	5
2023-06-26	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−5 sh	$183.15	−$915.75	0
2023-06-20	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−1,325 sh	$192.42	−$255K	0
2023-06-15	ONCBeOne Medicines Ltd.A Award	President, Global Head of R&D	AAward	+134K sh	—	—	1,614,431
2023-06-15	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	President, Global Head of R&D	AAward	+507K sh	—	—	507,234
2023-06-07	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−74 sh	$223.23	−$16.5K	388
2023-06-07	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−161 sh	$224.04	−$36.1K	227
2023-06-07	ONCBeOne Medicines Ltd.S Sale	President, Global Head of R&D	SSale	−111 sh	$225.27	−$25K	116

Recent filings

Accepted (ET)
Jun 254
Wang Lai0001852291-26-000007
SEC(opens sec.gov)
Jun 184
Wang Lai0001852291-26-000006
SEC(opens sec.gov)
Jun 154
Wang Lai0001852291-26-000005
SEC(opens sec.gov)
Jun 104
Wang Lai0001852291-26-000004
SEC(opens sec.gov)
Mar 104
Wang Lai0001852291-26-000003
SEC(opens sec.gov)
Jan 54
Wang Lai0001852291-26-000002
SEC(opens sec.gov)
Sep 114
Wang Lai0001651308-25-000142
SEC(opens sec.gov)
Jul 314
Wang Lai0001651308-25-000122
SEC(opens sec.gov)
Jul 224
Wang Lai0001651308-25-000120
SEC(opens sec.gov)
Jun 254
Wang Lai0001651308-25-000118
SEC(opens sec.gov)
Jun 184
Wang Lai0001651308-25-000113
SEC(opens sec.gov)
Jun 124
Wang Lai0001651308-25-000107
SEC(opens sec.gov)

Companies

BeOne Medicines Ltd.President, Global Head of R&DONC

Address

C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR

BASEL, 4051